foscarnet and ribavirin

foscarnet has been researched along with ribavirin in 33 studies

Research

Studies (33)

TimeframeStudies, this research(%)All Research%
pre-199012 (36.36)18.7374
1990's10 (30.30)18.2507
2000's5 (15.15)29.6817
2010's6 (18.18)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Corbett, TH; Court, BA; Kessel, D; Phadtare, S; Renis, HE; Zimlicka, J1
De Clercq, E1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Campillo, NE; Guerra, A; Páez, JA1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Choi, SS; Rasshofer, R; Roggendorf, M; Wölfl, P1
Hirsch, MS; Kaplan, JC1
Hirsch, MS; Schooley, RT; Vogt, M1
Frank, KB; McKernan, PA; Smee, DF; Smith, RA1
Pomerantz, RJ; Schooley, RT1
Bryson, YJ1
Mitchell, WM; Montefiori, DC; Robinson, WE1
Brunette, EN; DeBruin, M; Debs, RJ; Montgomery, AB; Shanley, JD1
Broder, S; Yarchoan, R1
Sandström, E1
Dolin, R1
Alenius, S1
Morris, DJ1
Brun-Vezinet, F; Pépin, JM; Simon, F1
Mahmood, W; Sacks, SL1
De Clercq, E; González, M; Jashés, M; López-Lastra, M; Sandino, A1
Beauchamp, D; Bergeron, MG; Désormeaux, A; Gourde, P; Harvie, P; Omar, RF; Tremblay, M1
Keating, MR1
Razonable, RR1
Andronova, VL; Deryabin, PG; Galegov, GA; Jasko, MV; Kukhanova, MK; Skoblov, YS1

Reviews

12 review(s) available for foscarnet and ribavirin

ArticleYear
Chemotherapeutic approaches to the treatment of the acquired immune deficiency syndrome (AIDS).
    Journal of medicinal chemistry, 1986, Volume: 29, Issue:9

    Topics: Acquired Immunodeficiency Syndrome; Adsorption; Antibodies, Viral; Antigens, Viral; Aurintricarboxylic Acid; Deltaretrovirus; Deoxycytidine; Foscarnet; Genes, Viral; Glycoproteins; Humans; Interferons; Male; Phosphonoacetic Acid; Retroviridae Infections; Reverse Transcriptase Inhibitors; Ribavirin; RNA, Viral; Suramin; Thymidine; Transcription, Genetic; Viral Proteins; Virus Replication; Zalcitabine; Zidovudine

1986
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Prospects of therapy for infections with human T-lymphotropic virus type III.
    Annals of internal medicine, 1985, Volume: 103, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Antimony; Antiviral Agents; Combined Modality Therapy; Deltaretrovirus; Foscarnet; Humans; Immunotherapy; Interferons; Lactams, Macrocyclic; Phosphonoacetic Acid; Receptors, Virus; Reverse Transcriptase Inhibitors; Ribavirin; RNA Processing, Post-Transcriptional; RNA, Viral; Suramin; Tungsten; Tungsten Compounds; Virus Replication

1985
Therapy of human immunodeficiency virus infections.
    Clinics in laboratory medicine, 1987, Volume: 7, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Foscarnet; Humans; Immunotherapy; Interferons; Oligodeoxyribonucleotides; Phosphonoacetic Acid; Ribavirin; Suramin; Thymidine; Zidovudine

1987
Promising new antiviral drugs.
    Journal of the American Academy of Dermatology, 1988, Volume: 18, Issue:1 Pt 2

    Topics: Acyclovir; Animals; Antiviral Agents; Bromodeoxyuridine; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Herpes Simplex; Herpes Zoster; Humans; Interferons; Phosphonoacetic Acid; Ribavirin; Thymidine; Zidovudine

1988
Progress in the development of antiviral therapy for HTLV-III-associated diseases.
    Important advances in oncology, 1987

    Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Foscarnet; HIV; Humans; Phosphonoacetic Acid; Ribavirin; Rifabutin; Rifamycins; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine

1987
Antiviral drugs for AIDS. Current status and future prospects.
    Drugs, 1986, Volume: 31, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Foscarnet; Humans; Interferon Type I; Phosphonoacetic Acid; Ribavirin; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine

1986
Adverse effects and drug interactions of clinical importance with antiviral drugs.
    Drug safety, 1994, Volume: 10, Issue:4

    Topics: Acyclovir; AIDS-Related Opportunistic Infections; Amantadine; Antiviral Agents; Didanosine; Drug Interactions; Foscarnet; Ganciclovir; Humans; Interferon-alpha; Ribavirin; Rimantadine; Vidarabine; Zalcitabine; Zidovudine

1994
[Is resistance of human immunodeficiency viruses (HIV) to nucleoside analogs an indication for their combined use?].
    Pathologie-biologie, 1993, Volume: 41, Issue:8 Pt 2

    Topics: Acyclovir; Didanosine; Drug Synergism; Drug Therapy, Combination; Female; Foscarnet; HIV-1; Humans; In Vitro Techniques; Male; Ribavirin; Zalcitabine; Zidovudine

1993
Anti-infective therapy for viral pneumonia.
    Seminars in respiratory infections, 1995, Volume: 10, Issue:4

    Topics: Acyclovir; Amantadine; Antiviral Agents; Foscarnet; Ganciclovir; Humans; Neuraminidase; Pneumonia, Viral; Ribavirin; Rimantadine

1995
Antiviral agents for non-human immunodeficiency virus infections.
    Mayo Clinic proceedings, 1999, Volume: 74, Issue:12

    Topics: 2-Aminopurine; Acetamides; Acyclovir; Amantadine; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Drugs, Investigational; Enzyme Inhibitors; Famciclovir; Foscarnet; Ganciclovir; Guanidines; Guanine; Humans; Interferons; Lamivudine; Neuraminidase; Organophosphonates; Organophosphorus Compounds; Oseltamivir; Pyrans; Ribavirin; Sialic Acids; Valacyclovir; Valine; Virus Diseases; Zanamivir

1999
Antiviral drugs for viruses other than human immunodeficiency virus.
    Mayo Clinic proceedings, 2011, Volume: 86, Issue:10

    Topics: Acyclovir; Adenine; Amantadine; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Foscarnet; Ganciclovir; Guanine; Hepatitis; Hepatitis B, Chronic; Hepatitis C; Herpesviridae Infections; HIV Infections; Humans; Influenza, Human; Interferons; Lamivudine; Nucleosides; Oligopeptides; Organophosphonates; Oseltamivir; Proline; Protease Inhibitors; Pyrimidinones; Ribavirin; Telbivudine; Thymidine; Valacyclovir; Valganciclovir; Valine; Virus Replication; Zanamivir

2011

Trials

2 trial(s) available for foscarnet and ribavirin

ArticleYear
[Chemotherapy and immunoprophylaxis of HIV infection].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1986, Nov-25, Volume: 75, Issue:48

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Foscarnet; HIV; Humans; Phosphonoacetic Acid; Reverse Transcriptase Inhibitors; Ribavirin; Suramin; Thymidine; Viral Vaccines; Virus Replication; Zidovudine

1986
Antiviral chemotherapy and chemoprophylaxis.
    Science (New York, N.Y.), 1985, Mar-15, Volume: 227, Issue:4692

    Topics: Acyclovir; Adult; Aged; Amantadine; Antiviral Agents; Chickenpox; Clinical Trials as Topic; Cytomegalovirus; Encephalitis; Foscarnet; Guanosine Triphosphate; Herpes Simplex; Herpes Zoster; Herpesviridae Infections; Humans; Infant, Newborn; Infant, Newborn, Diseases; Influenza A virus; Influenza, Human; Phosphonoacetic Acid; Respiratory Tract Infections; Ribavirin; Rimantadine; Vidarabine; Virus Diseases

1985

Other Studies

19 other study(ies) available for foscarnet and ribavirin

ArticleYear
Unsaturated and carbocyclic nucleoside analogues: synthesis, antitumor, and antiviral activity.
    Journal of medicinal chemistry, 1991, Volume: 34, Issue:1

    Topics: Adenosine Deaminase; Animals; Antimetabolites, Antineoplastic; Antiviral Agents; Cell Line; Cell Survival; Drug Screening Assays, Antitumor; Friend murine leukemia virus; HIV-1; HIV-2; Humans; Indicators and Reagents; Leukemia L1210; Mice; Molecular Structure; Nucleosides; Rauscher Virus; Structure-Activity Relationship

1991
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
    Bioorganic & medicinal chemistry, 2009, Jan-15, Volume: 17, Issue:2

    Topics: Anti-Infective Agents; Antiviral Agents; Artificial Intelligence; Computer Simulation; Drug Evaluation, Preclinical; Molecular Structure; Quantitative Structure-Activity Relationship

2009
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:3

    Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Interference of antiviral substances with replication of hepatitis delta virus RNA in primary woodchuck hepatocytes.
    Progress in clinical and biological research, 1991, Volume: 364

    Topics: Acyclovir; Animals; Antiviral Agents; Cells, Cultured; Foscarnet; Hepatitis Delta Virus; Liver; Marmota; Phosphonoacetic Acid; Ribavirin; RNA, Viral; Virus Replication

1991
Visna virus as an in vitro model for human immunodeficiency virus and inhibition by ribavirin, phosphonoformate, and 2',3'-dideoxynucleosides.
    Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:9

    Topics: Antimetabolites; Antiviral Agents; Deoxyribonucleosides; Deoxyribonucleotides; Foscarnet; HIV; Organophosphorus Compounds; Phosphonoacetic Acid; Reverse Transcriptase Inhibitors; Ribavirin; Ribonucleosides; Virus Replication; Visna-maedi virus

1987
In vitro evaluation of mismatched double-stranded RNA (ampligen) for combination therapy in the treatment of acquired immunodeficiency syndrome.
    AIDS research and human retroviruses, 1989, Volume: 5, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Alkaloids; Amphotericin B; Antiviral Agents; Drug Therapy, Combination; Foscarnet; HIV; Humans; In Vitro Techniques; Indolizines; Interferon beta-1a; Interferon beta-1b; Interferon Type I; Interferon-beta; Interferon-gamma; Interferons; Microbial Sensitivity Tests; Phosphonoacetic Acid; Recombinant Proteins; Ribavirin; RNA, Double-Stranded; Zidovudine

1989
Aerosol administration of antiviral agents to treat lung infection due to murine cytomegalovirus.
    The Journal of infectious diseases, 1988, Volume: 157, Issue:2

    Topics: Acyclovir; Administration, Oral; Aerosols; Animals; Antiviral Agents; Cytomegalovirus Infections; Disease Models, Animal; Female; Foscarnet; Ganciclovir; Mice; Mice, Inbred BALB C; Phosphonoacetic Acid; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Infectious; Ribavirin

1988
Inhibition of herpesvirus multiplication in guinea pig skin by antiviral compounds.
    Archives of virology, 1980, Volume: 65, Issue:2

    Topics: Animals; Antiviral Agents; Cytarabine; Foscarnet; Guinea Pigs; Herpes Simplex; Idoxuridine; Male; Organophosphorus Compounds; Phosphonoacetic Acid; Ribavirin; Simplexvirus; Skin; Vidarabine; Virus Replication

1980
Drugs for non-HIV viral infections.
    The Medical letter on drugs and therapeutics, 1994, Apr-01, Volume: 36, Issue:919

    Topics: Acyclovir; Amantadine; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Humans; Interferon-alpha; Ribavirin; Rimantadine; Virus Diseases

1994
Inhibitors of infectious pancreatic necrosis virus (IPNV) replication.
    Antiviral research, 1996, Volume: 29, Issue:2-3

    Topics: Adenosine; Adenosylhomocysteinase; Amides; Animals; Antiviral Agents; Cell Line; DNA; Foscarnet; Hydrolases; IMP Dehydrogenase; Infectious pancreatic necrosis virus; Orotidine-5'-Phosphate Decarboxylase; Pyrazoles; Ribavirin; Ribonucleosides; Ribose; Salmon; Viral Plaque Assay; Virus Replication

1996
Antiviral efficacy and toxicity of ribavirin and foscarnet each given alone or in combination in the murine AIDS model.
    Toxicology and applied pharmacology, 1997, Volume: 143, Issue:1

    Topics: Animals; Antiviral Agents; Drug Therapy, Combination; Epithelium; Foscarnet; Hematologic Tests; Immunoglobulin M; Kidney Tubules; Lymph Nodes; Mice; Mice, Inbred C57BL; Microscopy, Electron; Murine Acquired Immunodeficiency Syndrome; Organ Size; Ribavirin; Spleen

1997
Drugs for non-HIV viral infections.
    The Medical letter on drugs and therapeutics, 1997, Aug-01, Volume: 39, Issue:1006

    Topics: 2-Aminopurine; Abnormalities, Drug-Induced; Acyclovir; Amantadine; Antiviral Agents; Cidofovir; Contraindications; Cytosine; Drug Resistance, Microbial; Eye Infections, Viral; Famciclovir; Foscarnet; Ganciclovir; Guanine; Humans; Interferon-alpha; Kidney Diseases; Lamivudine; Organophosphonates; Organophosphorus Compounds; Prodrugs; Ribavirin; Rimantadine; Trifluridine; Valacyclovir; Valine; Virus Diseases

1997
Drugs for non-HIV viral infections.
    The Medical letter on drugs and therapeutics, 2002, Feb-04, Volume: 44, Issue:1123

    Topics: 2-Aminopurine; Acyclovir; Administration, Oral; Administration, Topical; Amantadine; Animals; Antiviral Agents; Cidofovir; Cytosine; Famciclovir; Foscarnet; Guanine; Herpesviridae Infections; Humans; Influenza, Human; Injections, Intravenous; Lamivudine; Organophosphonates; Organophosphorus Compounds; Rats; Ribavirin; Rimantadine; Thionucleotides; Trifluridine; Valacyclovir; Valine

2002
[Research of suppression of the herpes simplex virus reproduction with drug resistance by combination phosphite of acycloguanosine with some antiherpetic drugs].
    Voprosy virusologii, 2014, Volume: 59, Issue:6

    Topics: Acyclovir; Animals; Antiviral Agents; Chlorocebus aethiops; Cidofovir; Cytosine; Drug Resistance, Viral; Drug Synergism; Drug Therapy, Combination; Foscarnet; Glycyrrhizic Acid; Herpesvirus 1, Human; Humans; Interferon-alpha; Organophosphonates; Phosphites; Ribavirin; Vero Cells; Vidarabine; Virus Replication

2014